Related Experiment Video
Updated: Dec 27, 2025
09:53
In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
7.8K
Mitochondrial noncoding RNA-regulatory network in cardiovascular disease.
1Department of Biology, Faculty of Natural Sciences and Mathematics, University of Tuzla, Tuzla, Bosnia and Herzegovina.
Basic Research in Cardiology
|March 7, 2020
Summary
Mitochondrial noncoding RNAs (ncRNAs) regulate cardiovascular metabolism and pathogenesis. Understanding these ncRNAs offers potential for novel cardiovascular disease (CVD) biomarkers and therapies.
Area of Science:
- Cardiovascular Biology
- Mitochondrial Medicine
- Molecular Genetics
Background:
- Mitochondrial function is crucial for cardiomyocyte ATP production, with dysfunction linked to cardiovascular disease (CVD).
- Noncoding RNAs (ncRNAs) within mitochondria are emerging regulators of cellular homeostasis and disease pathways.
- Mitochondrial ncRNAs influence glycolysis, energy status, and gene expression in cardiovascular metabolism.
Purpose of the Study:
- To review the role of mitochondrial ncRNAs in cardiovascular pathology.
- To discuss mitochondrial microRNAs (mitomiRs) and long noncoding RNAs (lncRNAs) in CVD regulation.
- To explore the biomarker and therapeutic potential of mitochondrial ncRNAs in CVD.
Main Methods:
- Literature review of mitochondrial ncRNAs in cardiovascular research.
- Analysis of studies on mitomiRs and lncRNAs in CVD pathogenesis.
- Evaluation of current and future clinical applications of mitochondrial ncRNAs.
Main Results:
- Mitochondrial ncRNAs (mitomiRs, lncRNAs) are involved in regulating mitochondrial metabolism.
- These ncRNAs play roles in the pathogenesis of hypertension, cardiac hypertrophy, myocardial infarction, and heart failure.
- Mitochondrial ncRNAs show promise as biomarkers and therapeutic targets for CVD.
Conclusions:
- Mitochondrial ncRNAs are key players in the complex regulatory network of cardiovascular pathology.
- Further research into mitochondrial ncRNAs can lead to improved prevention and treatment strategies for CVD.
- Challenges remain in translating the clinical application of mitochondrial ncRNAs.
More Related Videos
07:03Author Spotlight: Uncovering the Role of Mitochondrial Calcium Phosphate in Heart Failure and Bioenergetics
Published on: August 23, 2024
1.4K
11:26Analyzing Oxygen Consumption Rate in Primary Cultured Mouse Neonatal Cardiomyocytes Using an Extracellular Flux Analyzer
Published on: February 13, 2019
9.1K
Related Concept Videos
01:27Regulation of the Cardiovascular System
3.4K
The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
3.4K
01:31Regulation of Heart Rates
3.6K
The regulation of heart rate is a complex process controlled by the autonomic nervous system (ANS), hormonal influences, and intrinsic cardiac mechanisms. The ANS has two main components: the sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS).
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
3.6K
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
375
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
375
01:26Coronary Artery Disease II: Pathophysiology
300
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
300
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
297
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
297
01:25Cardiomyopathy I: Introduction and Classification
418
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
418